The effect of purmorphamine on differentiation of endometrial stem cells into osteoblast-like cells on collagen/hydroxyapatite scaffolds. (3rd October 2017)

• Record Type: Journal Article
• Authors: Bahrami, Naghmeh; Malekolkottab, Fatemeh; Ebrahimi-Barough, Somayeh; Alizadeh Tabari, Zahra; Hamisi, Jalaleddin; Kamyab, Ahmadreza; Mohamadnia, Abdolreza; Ai, Armin; Bayat, Farshad; Bahrami, Naeim; Ai, Jafar
• Is Part Of: Artificial cells, nanomedicine, and biotechnology. Volume 45:Number 7(2017)
• Page Start: 1343
• Page End: 1349
• Publication Date: 2017-10-03
• Subjects: hEnSCs -- bone tissue engineering -- collagen/hydroxyapatite scaffold -- purmorphamin; Artificial cells -- Periodicals; Nanotechnology -- Periodicals; Blood substitutes -- Periodicals; Tissue engineering -- Periodicals; Molecules -- Periodicals; Biotechnology -- Periodicals; 615.39
• DOI: 10.1080/21691401.2016.1236804
• Languages: English
• ISSNs: 2169-1401

Abstract

Abstract: We assessed the effect of purmorphamine along with collagen/hydroxyapatite scaffold in inducing osteogenesis of human endometrial stem cells (hEnSCs). The adhesion, viability, proliferation, and differentiation of cells on scaffold were assayed with SEM, MTT, real time-PCR, and ALP assay, respectively. The results were shown good integration of cells with scaffold. Also, qRT-PCR of differentiated cells shows that osteoblast cell markers are expressed after 21d in 2D and scaffold groups while in the scaffold group the expression of these markers were higher than the 2D group. Based on our findings, collagen/hydroxyapatite scaffold with PMA has the potential role in osteogenic differentiation of hEnSCs.